Business
South African variant can ‘break through’ Pfizer vaccine, Israeli study says – Sydney Morning Herald
The coronavirus variant discovered in South Africa can “break through” Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found….
Jerusalem: The coronavirus variant discovered in South Africa can break through Pfizer/BioNTechs COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer reviewed.
The study, released on Sunday (AEST), compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease. It…
-
Business18 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business22 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business14 hours agoDicker Data rides the AI trend to double digit growth
-
Business17 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy